Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Risks of testosterone-replacement therapy and recommendations for monitoring.

Rhoden EL, Morgentaler A.

N Engl J Med. 2004 Jan 29;350(5):482-92. Review. No abstract available.

PMID:
14749457
2.

Testosterone replacement therapy and prostate cancer: a word of caution.

Brand TC, Canby-Hagino E, Thompson IM.

Curr Urol Rep. 2007 May;8(3):185-9. Review.

PMID:
17459266
3.

Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR.

J Androl. 2003 May-Jun;24(3):299-311. Review. No abstract available.

4.

[Testosterone and the prostate].

Sperling H, Rossi R, Lümmen G, Rübben H.

Urologe A. 2004 Sep;43(9):1092-6. Review. German.

PMID:
15368045
5.

Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.

Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H.

Postgrad Med. 2011 May;123(3):17-27. doi: 10.3810/pgm.2011.05.2280.

PMID:
21566412
6.

[Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].

Rinnab L, Gust K, Hautmann RE, Küfer R.

Urologe A. 2009 May;48(5):516-22. doi: 10.1007/s00120-009-1954-z. Review. German.

PMID:
19296069
7.

Clinical hypogonadism and androgen replacement therapy: an overview.

Ohl DA, Quallich SA.

Urol Nurs. 2006 Aug;26(4):253-9, 269; quiz 260. Review.

PMID:
16939042
8.

[Testosterone substitution in aging males. Which questions are answered?].

Krause W.

Urologe A. 2004 Sep;43(9):1097-100. Review. German.

PMID:
15368046
9.

Testosterone deficiency and replacement.

Howell S, Shalet S.

Horm Res. 2001;56 Suppl 1:86-92. Review.

PMID:
11786693
10.

[Testosterone therapy].

Diemer T, Hauptmann A, Wagenlehner FM.

Urologe A. 2016 Apr;55(4):539-48; quiz 549-50. doi: 10.1007/s00120-016-0072-y. Review. German.

PMID:
27067659
11.

Testosterone and prostate cancer: what are the risks for middle-aged men?

Morgentaler A.

Urol Clin North Am. 2011 May;38(2):119-24. doi: 10.1016/j.ucl.2011.02.002. Epub 2011 Apr 13. Review.

PMID:
21621078
14.

Testosterone replacement therapy for older men.

Wald M, Meacham RB, Ross LS, Niederberger CS.

J Androl. 2006 Mar-Apr;27(2):126-32. Review. No abstract available.

15.

Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.

Coward RM, Simhan J, Carson CC 3rd.

BJU Int. 2009 May;103(9):1179-83. doi: 10.1111/j.1464-410X.2008.08240.x. Epub 2008 Dec 23.

16.

[Testosterone substitution in patients with hypogonadism].

Martínez Portillo FJ, Cueva Martínez A, Martin Braun P, Fernández Arancibia MI, Jünemann KP, Alken P.

Arch Esp Urol. 2002 Sep;55(7):827-38. Review. Spanish.

PMID:
12380312
17.

Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?

Landau D, Tsakok T, Aylwin S, Hughes S.

Clin Endocrinol (Oxf). 2012 Feb;76(2):179-81. doi: 10.1111/j.1365-2265.2011.04233.x.

PMID:
21951017
18.
19.

[Andrological testosterone replacement therapy].

Paasch U, Glander HJ, Stolzenburg JU.

Urologe A. 2009 Jan;48(1):79-86; quiz 87. doi: 10.1007/s00120-008-1911-2. Review. German.

PMID:
19156339
20.

Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?

Gould DC, Kirby RS.

Prostate Cancer Prostatic Dis. 2006;9(1):14-8. Review.

PMID:
16264770

Supplemental Content

Support Center